MXCTMaxCyteMXCT info
$4.24info2.42%24h
Global rank12409
Market cap$439.16M
Change 7d-0.24%
YTD Performance-9.21%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    MaxCyte (MXCT) Stock Overview

    MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

    MXCT Stock Information

    Symbol
    MXCT
    Address
    9713 Key West AvenueRockville, MD 20850United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://maxcyte.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    301 944 1700

    MaxCyte (MXCT) Price Chart

    -
    Value:-

    MaxCyte Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.24
    N/A
    Market Cap
    $439.16M
    N/A
    Shares Outstanding
    103.58M
    N/A
    Employees
    125.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org